The trajectory of Viagra presents a challenging picture for investors. While the initial launch generated significant profits, the end of its patent opened the avenue to off-brand versions, dramatically diminishing https://growthbookmarks.com/story21598668/viagra-and-pharma-a-risky-opportunity